Clinical trials recruiting in Bellinzona, Switzerland

Phase breakdown

Conditions recruiting in Bellinzona, Switzerland

Recruiting trials in Bellinzona, Switzerland

• A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
  NCT06428409 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• A Single-centre Study Evaluating the Performance and Acceptance of the Hilo Band Cuffless Blood Pressure Medical Device in the Normo-, Hypo- and Hyper-tensive Young Population: a Comparison With the 24-h Ambulatory Blood Pressure Monitoring (ABPM)
  NCT07072689 · Phase: Not specified · Ages: 21 Years to 35 Years · Sex: All (male and female)
• A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment in Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer: RADIOpharmaceutical DOSimetry Evaluation (RADIODOSE) Study
  NCT06531499 · Phase: Phase 1 · Ages: 18 Years to 100 Years · Sex: Male
• A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
  NCT06561386 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
  NCT07361497 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer.
  NCT06284317 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)
  NCT04916613 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male
• Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment
  NCT04045691 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland
  NCT03124212 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Combination Study of Antibiotics With Enzalutamide (PROMIZE)
  NCT06126731 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male
• Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  NCT06401980 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male
• Effect of a Music Intervention in Reducing Distress and Pain in Patients With Lung Cancer Undergoing Mini-invasive Surgery
  NCT07235098 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
  NCT03567889 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Evaluation of Sleep Quality in Prostate Cancer Patients Undergoing Treatment With Hormonal Therapeutic Approaches and in Patients With Full-resected Early Breast Cancer
  NCT04543799 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Giving Children a Voice in Paediatric Anaesthesia
  NCT07524049 · Phase: Not specified · Ages: 6 Years and older · Sex: All (male and female)
• International Registry for Men With Advanced Prostate Cancer (IRONMAN)
  NCT03151629 · Phase: Not specified · Ages: 21 Years and older · Sex: Male
• Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early TNBC. INVINCIBLE-4-SAKK
  NCT06358573 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer
  NCT07002320 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male
• LUCINAE Registry: Thoracic Cancers During Pregnancy
  NCT07699861 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Lifestyle Intervention in Patients With Metastatic Prostate Cancer
  NCT05850182 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male
• Metronidazole as Preoperative Therapy in CRC / FusoMetro-001
  NCT05748145 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
  NCT06780670 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 100 Years · Sex: Male
• Overcoming Resistance to Immunotherapy Combining Gemcitabine With Ivonescimab in Advanced NSCLC
  NCT07158489 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
  NCT04221542 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male
• Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
  NCT05489211 · Phase: Phase 2 · Ages: 18 Years to 130 Years · Sex: All (male and female)
• Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
  NCT07100080 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)
  NCT05017142 · Phase: Not specified · Ages: Up to 36 Years · Sex: All (male and female)
• Teleconsultation vs Face-to-Face Evaluation for Perioperative Respiratory Events in Pediatric Adenotonsillectomy
  NCT07175779 · Phase: Not applicable (e.g. observational or device study) · Ages: Up to 16 Years · Sex: All (male and female)
• Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro)
  NCT07365423 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male
• Trial Comparing Systemic Therapy Alone and With Local Ablative Treatment for Stage IV NSCL Cancer Patients
  NCT06114108 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer
  NCT03819101 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male
• Valid Biomarkers in Blood to Predict the Response to Therapy in Prostate Cancer Patients
  NCT03408964 · Phase: Not specified · Ages: 18 Years and older · Sex: Male

Common questions

How many clinical trials are recruiting in Bellinzona, Switzerland?

32 recruiting trials have at least one study site in Bellinzona, Switzerland.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.